1. Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013; 46:1323–1338.
2. Kamenetsky Z, Da'as N, Esayag Y, Kleinman Y, Samuels N. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Neurologist. 2012; 18:39–40.
3. Choi KH, Nam TS, Kim JT, Choi SM, Park MS, Kim BC, et al. Valproate associated diffuse alveolar hemorrhage. Eur J Neurol. 2011; 18:e98–e99.
4. Bullington W, Sahn SA, Judson MA. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Am J Med Sci. 2007; 333:290–292.
5. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am Rev Respir Dis. 1986; 133:488–505.
6. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986; 133:321–340.
7. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004; 71:301–326.
8. Shi JH, Yan XW, Xu WB, Liu HR, Zhu YJ. Clinicopathological manifestations of drug-induced lung injury. Zhonghua Jie He He Hu Xi Za Zhi. 2007; 30:161–166.
9. Matsuno O. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res. 2012; 13:39.